Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

39.78 

0.23 0.6%

as of Jul 16 '19

52 Week Range:

29.05 40.01


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Koninklijke Philips N.V. operates as a health technology company worldwide. It operates through Diagnosis & Treatment, Connected Care & Health Informatics, and Personal Health segments. The company offers mother, child care, and oral healthcare products; male grooming and beauty products; food preparation and home care products; and sleep and respiratory care. It provides diagnostic X-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. The company also offers interventional X-ray systems, and imaging and therapy devices for treatment of coronary artery and peripheral vascular disease; imaging products focus on diagnosis, treatment planning, and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; and proprietary software to enable diagnostics and intervention. Further, it provides patient monitoring solutions; patient analytics, precision diagnosis, and clinical decision support systems; therapeutic care products; patient monitoring and therapeutic care consumables; and customer services. Additionally, the company offers healthcare information technology, clinical, and visualization and quantification informatics solutions for radiology, cardiology, and oncology departments; universal data management solutions, picture archiving and communication systems, and integrated electronic medical record systems; clinical and hospital IT platforms; technology-enabled monitoring and intervention, actionable program, cloud-based, and population health management software solutions. It also provides digital frameworks that connect consumers, patients, and healthcare providers in a cloud-based connected health ecosystem of devices, apps, and tools. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 17.60
15.74
15.90
13.94
12.18
11.64
11.93
12.48
12.60
12.32
12.78
growth rate -10.6% 1.0% -12.3% -12.6% -4.4% 2.5% 4.6% 1.0% -2.2% 3.7%
Earnings BIT 92.00
448.00
1,940.00
-509.00
784.00
1,858.00
679.00
546.00
1,688.00
1,752.00
1,889.00
growth rate 387.0% 333.0% -100.0% 100.0% 137.0% -63.5% -19.6% 209.2% 3.8% 7.8%
Avg.PE -225.40
45.05
15.02
-21.50
70.92
20.96
10.53
10.53
17.78
18.28
29.09
growth rate 100.0% -66.7% -100.0% 100.0% -70.5% -49.8% 0.0% 68.9% 2.8% 59.1%
ROA -0.54
1.29
4.61
-4.23
0.78
4.20
1.51
2.17
4.58
5.75
4.25
growth rate 100.0% 257.4% -100.0% 100.0% 438.5% -64.1% 43.7% 111.1% 25.6% -26.1%
ROE -0.98
2.66
9.76
-9.45
1.92
10.46
3.76
5.73
11.94
13.47
9.05
growth rate 100.0% 266.9% -100.0% 100.0% 444.8% -64.1% 52.4% 108.4% 12.8% -32.8%
ROIC -0.47
2.75
7.97
-6.21
2.35
9.13
4.48
5.39
10.25
9.85
7.30
growth rate 100.0% 189.8% -100.0% 100.0% 288.5% -50.9% 20.3% 90.2% -3.9% -25.9%
Cur. Ratio 1.44
1.48
1.36
1.34
1.26
1.35
1.34
1.26
1.34
1.47
1.21
growth rate 2.8% -8.1% -1.5% -6.0% 7.1% -0.7% -6.0% 6.4% 9.7% -17.7%
Quick Ratio 0.89
1.04
0.95
0.83
0.86
0.85
0.74
0.68
0.76
0.86
0.83
growth rate 16.9% -8.7% -12.6% 3.6% -1.2% -12.9% -8.1% 11.8% 13.2% -3.5%
Leverage 2.03
2.09
2.14
2.34
2.61
2.37
2.60
2.66
2.56
2.11
2.15
growth rate 3.0% 2.4% 9.4% 11.5% -9.2% 9.7% 2.3% -3.8% -17.6% 1.9%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 3,837.00
3,683.00
4,124.00
4,584.00
4,334.00
4,748.00
4,988.00
5,322.00
5,709.00
4,204.00
4,458.00
growth rate -4.0% 12.0% 11.2% -5.5% 9.6% 5.1% 6.7% 7.3% -26.4% 6.0%
Acct.Payable 2,462.00
2,499.00
2,673.00
2,848.00
2,090.00
2,303.00
growth rate 1.5% 7.0% 6.6% -26.6% 10.2%
Cur.Assets 12,149.00
11,909.00
14,597.00
12,893.00
12,528.00
11,474.00
12,391.00
12,693.00
14,075.00
10,117.00
9,572.00
growth rate -2.0% 22.6% -11.7% -2.8% -8.4% 8.0% 2.4% 10.9% -28.1% -5.4%
Total Assets 31,910.00
30,527.00
32,269.00
29,395.00
29,081.00
26,559.00
28,352.00
30,976.00
32,270.00
25,315.00
26,019.00
growth rate -4.3% 5.7% -8.9% -1.1% -8.7% 6.8% 9.3% 4.2% -21.6% 2.8%
Cash 3,620.00
4,386.00
5,833.00
3,147.00
3,834.00
2,465.00
1,873.00
1,766.00
2,334.00
1,939.00
1,688.00
growth rate 21.2% 33.0% -46.1% 21.8% -35.7% -24.0% -5.7% 32.2% -16.9% -12.9%
Inventory 3,491.00
2,913.00
3,865.00
3,625.00
3,495.00
3,240.00
3,314.00
3,463.00
3,392.00
2,353.00
2,674.00
growth rate -16.6% 32.7% -6.2% -3.6% -7.3% 2.3% 4.5% -2.1% -30.6% 13.6%
Cur.Liabilities 9,033.00
8,050.00
10,758.00
9,784.00
9,955.00
8,476.00
8,676.00
9,959.00
10,473.00
6,866.00
7,943.00
growth rate -10.9% 33.6% -9.1% 1.8% -14.9% 2.4% 14.8% 5.2% -34.4% 15.7%
Liabilities 16,366.00
15,932.00
17,223.00
17,079.00
17,930.00
15,332.00
17,384.00
19,196.00
18,817.00
13,292.00
13,902.00
growth rate -2.7% 8.1% -0.8% 5.0% -14.5% 13.4% 10.4% -2.0% -29.4% 4.6%
LT Debt 3,466.00
3,640.00
2,818.00
3,278.00
3,725.00
3,164.00
3,571.00
3,950.00
3,827.00
3,849.00
3,191.00
growth rate 5.0% -22.6% 16.3% 13.6% -15.1% 12.9% 10.6% -3.1% 0.6% -17.1%
Equity 15,544.00
14,595.00
15,046.00
12,316.00
11,151.00
11,214.00
10,867.00
11,662.00
12,546.00
11,999.00
12,088.00
growth rate -6.1% 3.1% -18.1% -9.5% 0.6% -3.1% 7.3% 7.6% -4.4% 0.7%
Common Shares 997.00
929.00
949.00
957.00
927.00
922.00
923.00
924.00
929.00
945.00
936.00
growth rate -6.8% 2.2% 0.8% -3.1% -0.5% 0.1% 0.1% 0.5% 1.7% -1.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 600.00
-126.00
-129.00
-128.00
-425.00
482.00
437.00
432.00
360.00
420.00
422.00
growth rate -100.0% 0.0% 0.0% 0.0% 100.0% -9.3% -1.1% -16.7% 16.7% 0.5%
Cash Dividends 698.00
634.00
296.00
259.00
255.00
272.00
292.00
298.00
330.00
384.00
401.00
growth rate -9.2% -53.3% -12.5% -1.5% 6.7% 7.4% 2.1% 10.7% 16.4% 4.4%
Cash From OA 1,599.00
1,545.00
2,074.00
768.00
2,082.00
844.00
1,408.00
1,135.00
3,321.00
2,933.00
2,427.00
growth rate -3.4% 34.2% -63.0% 171.1% -59.5% 66.8% -19.4% 192.6% -11.7% -17.3%
FCF per Share 0.56
1.00
1.27
-0.34
1.23
0.41
0.69
0.09
0.95
1.30
0.95
growth rate 78.6% 27.0% -100.0% 100.0% -66.7% 68.3% -87.0% 955.6% 36.8% -26.9%
Sale Purchase of Stock 117.00
81.00
80.00
227.00
growth rate -30.8% -1.2% 183.8%
FCF 554.00
925.00
1,204.00
-275.00
1,137.00
145.00
457.00
210.00
1,035.00
1,011.00
936.00
growth rate 67.0% 30.2% -100.0% 100.0% -87.3% 215.2% -54.1% 392.9% -2.3% -7.4%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 26,385.00
23,189.00
22,287.00
22,579.00
23,457.00
21,990.00
21,391.00
16,806.00
17,422.00
17,780.00
18,121.00
growth rate -12.1% -3.9% 1.3% 3.9% -6.3% -2.7% -21.4% 3.7% 2.1% 1.9%
Op.Income 54.00
614.00
2,074.00
-269.00
648.00
1,858.00
679.00
546.00
1,688.00
1,752.00
1,889.00
growth rate 1,037.0% 237.8% -100.0% 100.0% 186.7% -63.5% -19.6% 209.2% 3.8% 7.8%
IBT 142.00
448.00
1,953.00
-509.00
319.00
1,661.00
247.00
328.00
1,034.00
1,377.00
1,503.00
growth rate 215.5% 335.9% -100.0% 100.0% 420.7% -85.1% 32.8% 215.2% 33.2% 9.2%
Net Income -91.00
410.00
1,442.00
-1,295.00
-35.00
1,169.00
415.00
624.00
1,448.00
1,657.00
1,090.00
growth rate 100.0% 251.7% -100.0% 0.0% 100.0% -64.5% 50.4% 132.1% 14.4% -34.2%
EPS -0.09
0.44
1.52
-1.53
-0.04
1.27
0.45
0.68
1.56
1.75
1.16
growth rate 100.0% 245.5% -100.0% 0.0% 100.0% -64.6% 51.1% 129.4% 12.2% -33.7%
Gross Profit 8,447.00
8,079.00
9,022.00
8,734.00
8,991.00
9,385.00
8,206.00
7,212.00
7,964.00
8,278.00
8,632.00
growth rate -4.4% 11.7% -3.2% 2.9% 4.4% -12.6% -12.1% 10.4% 3.9% 4.3%
R&D 1,777.00
1,631.00
1,493.00
1,610.00
1,831.00
1,733.00
1,635.00
1,562.00
1,648.00
1,670.00
1,695.00
growth rate -8.2% -8.5% 7.8% 13.7% -5.4% -5.7% -4.5% 5.5% 1.3% 1.5%

Quarterly Statements

Item Name Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Earnings BIT 202.00
298.00
450.00
940.00
245.00
growth rate 47.5% 51.0% 108.9% -73.9%
Balance Sheet Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Acct.Receivable 3,601.00
4,458.00
growth rate 11.3%
Acct.Payable 1,781.00
2,303.00
growth rate 13.7%
Cur.Assets 9,064.00
9,572.00
growth rate 2.8%
Total Assets 24,824.00
26,019.00
growth rate 2.4%
Cash 1,615.00
1,688.00
growth rate 2.2%
Inventory 2,700.00
2,674.00
growth rate -0.5%
Cur.Liabilities 7,123.00
7,943.00
growth rate 5.6%
Liabilities 13,124.00
13,902.00
growth rate 2.9%
LT Debt 3,688.00
3,191.00
growth rate -7.0%
Equity 11,999.00
11,678.00
11,678.00
12,088.00
12,088.00
growth rate -2.7% 0.0% 3.5% 0.0%
Common Shares 190.00
185.00
growth rate -1.3%
Cash Flow Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Capital Expenditures 139.00
13.00
212.00
58.00
220.00
growth rate -90.7% 1,530.8% -72.6% 279.3%
Cash Dividends 341.00
341.00
51.00
9.00
growth rate 0.0% -85.0% -82.4%
Cash From OA 611.00
181.00
252.00
1,383.00
14.00
growth rate -70.4% 39.2% 448.8% -99.0%
Sale Purchase of Stock 72.00
72.00
growth rate 0.0%
FCF 472.00
168.00
40.00
1,325.00
-206.00
growth rate -64.4% -76.2% 3,212.5% -100.0%
Income Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Sales 3,942.00
4,288.00
4,306.00
5,586.00
4,151.00
growth rate 8.8% 0.4% 29.7% -25.7%
Op.Income 202.00
298.00
450.00
940.00
245.00
growth rate 47.5% 51.0% 108.9% -73.9%
IBT 122.00
248.00
421.00
710.00
238.00
growth rate 103.3% 69.8% 68.7% -66.5%
Net Income 125.00
291.00
673.00
164.00
growth rate 52.6% 131.3% -75.6%
EPS
growth rate
Gross Profit 1,786.00
2,006.00
2,074.00
2,767.00
1,888.00
growth rate 12.3% 3.4% 33.4% -31.8%
R&D 433.00
425.00
415.00
422.00
439.00
growth rate -1.9% -2.4% 1.7% 4.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (18.20)

YOY Growth Grade:

F (10.05)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 32.37 32.79 21.46
EPS / Growth 1.6% 1.21 8.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 1.3% 1.3%
Future PE 2.00 18.81 18.81
Future EPS 1.34 1.38 1.38
Value Price
MOS %
0.66
-98.3%
6.42
-83.9%
6.42
-83.9%
MOS Price 0.33 3.21 3.21
IRT 28.26 27.19 27.19

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.